Parkinson’s disease, bruxism, and its clinical consequences.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON19915

Enrollment

246

Registered

2020-01-19

Start date

2020-03-29

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: - Patients who visit the outpatient clinic for movement disorders of the VUmc hospital with (presumable) PD. - Adults (>18 years old)

Exclusion criteria

Exclusion criteria: - Children or adolescents (<18 years old) - Patients with a pacemaker (only excluded for using GrindCare®) - Patients without an available smartphone (only excluded for using the mobile application BruxApp) - Patients who do not fulfil the clinical diagnostic criteria for PD - Patients with atypical parkinsonian syndromes - Montreal Cognitive Assessment (MoCA) score < 21

Design outcomes

Primary

Measure	Time frame
Probable/definite sleep bruxism and awake bruxism; temporomandibular disorders	—

Secondary

Measure	Time frame
Several variables will be evaluated: disease stage, disease severity, medication use, cognitive function, neuropsychiatric symptoms, quality of sleep, stimulant use (alcohol, smoking and drugs), reflux, dry mouth.	—

Contacts

Public ContactM.C. Verhoeff

Academic Centre for Dentistry Amsterdam (Academisch Centrum voor Tandheelkunde Amsterdam, ACTA)

m.c.verhoeff@acta.nl(020) 5980380

Outcome results